Ausgabe 3/2024
Inhalt (20 Artikel)
Biomarkers predictive of a response to extended endocrine therapy in breast cancer: a systematic review and meta-analysis
Kirsten M. Woolpert, Thomas P. Ahern, Timothy L. Lash, Donna L. O’Malley, Alice M. Stokes, Deirdre P. Cronin-Fenton
Nodal pCR and overall survival following neoadjuvant chemotherapy for node positive ER+/Her2- breast cancer
Dan Moldoveanu, Tanya L. Hoskin, Courtney N. Day, Amy K. Schulze, Matthew P. Goetz, Judy C. Boughey
Association of physical weight statuses defined by body mass index (BMI) with molecular subtypes of premenopausal breast cancer: a systematic review and meta-analysis
Xuchu Li, Jinping Li, Qirui Hu, Xu Zhang, Fang Chen
Olaparib enhances sensitization of BRCA-proficient breast cancer cells to x-rays and protons
Sohee Park, Changhoon Choi, Haeyoung Kim, Yong Jae Shin, Yunjeong Oh, Won Park, Won Kyung Cho, Nalee Kim
Outcomes of male patients with HR+/HER2– advanced breast cancer receiving palbociclib in the real-world POLARIS study
Joanne L. Blum, Caroline DiCristo, David Gordon, Meghan S. Karuturi, David Oubre, Erin Jepsen, Juan Cuevas, Shailendra Lakhanpal, Monica Z. Montelongo, Zhe Zhang, Joseph C. Cappelleri, Yao Wang, Debu Tripathy
Optimizing surgical strategy in locally advanced breast cancer: a comparative analysis between preoperative MRI and postoperative pathology after neoadjuvant chemotherapy
K. K. Rajan, C. Boersma, M. A. Beek, T. A. Berendsen, J. van der Starre-Gaal, M. van ’t Veer-ten Kate, A. B. Francken, E. M. Noorda
Unveiling the HER2-low phenomenon: exploring immunohistochemistry and gene expression to characterise HR-positive HER2-negative early breast cancer
M. Gaudio, F. Jacobs, C. Benvenuti, G. Saltalamacchia, R. Gerosa, R. De Sanctis, A. Santoro, A. Zambelli
The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study
Diogo Martins-Branco, Marie Kassapian, Véronique Debien, Rafael Caparica, Daniel Eiger, Urania Dafni, Charitini Andriakopoulou, Sarra El-Abed, Susan L. Ellard, Miguel Izquierdo, Malou Vicente, Saranya Chumsri, Martine Piccart-Gebhart, Alvaro Moreno-Aspitia, Ann Søegaard Knop, Janine Lombard, Evandro de Azambuja
Positive predictive value of axillary lymph node cortical thickness and nodal, clinical, and tumor characteristics in newly diagnosed breast cancer patients
Anne-Sophie T. Loonis, Allyson L. Chesebro, Camden P. Bay, Leah H. Portnow, Anna Weiss, Sona A. Chikarmane, Catherine S. Giess
European quality indicators developed by the European Commission Initiative on Breast Cancer: a first nationwide assessment for the Dutch setting
Kay Schreuder, Tim J. Bult, Babet Stroop, Linetta B. Koppert, Rhodé M. Bijlsma, Enja J. Bantema-Joppe, Marije J. Hoornweg, Sabine Siesling
Risk of contralateral breast cancer among Asian/Pacific Islander women in the United States
Hsiao-Ching Huang, Jenny S. Guadamuz, Kent F. Hoskins, Naomi Y. Ko, Gregory S. Calip
Secretory breast carcinoma: clinicopathological features and prognosis of 52 patients
Yuan-Yuan Zhao, Hui-Juan Ge, Wen-Tao Yang, Zhi-Ming Shao, Shuang Hao
Racial/ethnic disparities in the association between patient care experiences and receipt of initial surgical breast cancer care: findings from SEER-CAHPS
Mariana Arevalo, Trevor A. Pickering, Sally W. Vernon, Kayo Fujimoto, Melissa F. Peskin, Albert J. Farias
Assessment of breast cancer chemotherapy dose reduction in an integrated healthcare delivery system
Elizabeth D. Kantor, Kelli O’Connell, Isaac J. Ergas, Emily Valice, Janise M. Roh, Jenna Bhimani, Narre Heon, Jennifer J. Griggs, Jean Lee, Erin JA Bowles, Donna R. Rivera, Tatjana Kolevska, Elisa V Bandera, Lawrence H Kushi
Individual and area level factors associated with the breast cancer diagnostic-treatment interval in Queensland, Australia
James D. Retell, Jessica K. Cameron, Joanne F. Aitken, Philippa Youl, Chris Pyke, Jeff Dunn, Suzanne Chambers, Peter D. Baade
A new methodology to predict the oncotype scores based on clinico-pathological data with similar tumor profiles
Zeina Al Masry, Romain Pic, Clément Dombry, Chrisine Devalland
Screening mammographic performance by race and age in the National Mammography Database: 29,479,665 screening mammograms from 13,181,241 women
Cindy S. Lee, Lenka Goldman, Lars J. Grimm, Ivy Xinyue Liu, Michael Simanowith, Robert Rosenberg, Margarita Zuley, Linda Moy
Palbociclib sensitizes ER-positive breast cancer cells to fulvestrant by promoting the ubiquitin-mediated degradation of ER-α via SNHG17/Hippo-YAP axis
Lei Lei, Yuan Huang, Lei Shi, Weiwu Ye, Xianmei Lv, Lisha Ying, Xingfei Yu, Skye Hung-Chun Cheng, Yabing Zheng
Interleukin-6 and C-Reactive protein in metastatic breast cancer patients treated with eribulin
Kadri Altundag